Viewing Study NCT01405560


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-01-03 @ 4:04 PM
Study NCT ID: NCT01405560
Status: COMPLETED
Last Update Posted: 2018-10-18
First Post: 2011-07-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)
Sponsor: Merck Sharp & Dohme LLC
Organization: